Literature DB >> 12509970

Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma.

Yutaka Yamazaki1, Itsuo Chiba, Atsuko Hirai, Chihiro Sugiura, Ken-ichi Notani, Haruhiko Kashiwazaki, Kanchu Tei, Yasunori Totsuka, Hiroshi Fukuda.   

Abstract

In this study, we focused on p53 mutations in specific regions, including DNA-binding surface regions, to clarify the correlation between mutations within the specific regions of p53 and clinical outcomes of patients with oral cancers. We analyzed p53 mutations in 121 fresh primary oral squamous cell carcinomas (SCCs) by polymerase chain reaction-single-strand conformation polymorphism or a yeast functional assay. p53 mutations were detected in 51/121 (42%) cases. Mutation of p53 was not associated with any clinicopathological parameters; however, tumors containing specific p53 mutations, e.g. DNA-binding surface regions (L2, L3 and the LSH motif) and conserved regions (II-V), had significantly poorer prognoses than tumors with mutations outside of those regions. Moreover, locoregional failure, lymph node metastasis and the occurrence of subsequent distant metastasis were also significantly associated with mutations within DNA-binding surface regions. These data indicate that specific mutations of p53 could be important prognostic factors in oral SCCs. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12509970     DOI: 10.1016/s1368-8375(02)00064-7

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  7 in total

Review 1.  Biomarkers of head and neck cancer, tools or a gordian knot?

Authors:  Evangeli S Lampri; Georgios Chondrogiannis; Elli Ioachim; Anna Varouktsi; Antigoni Mitselou; Aggeliki Galani; Evangelos Briassoulis; Panagiotis Kanavaros; Vasiliki Galani
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study.

Authors:  Jenni K Peltonen; Kirsi H Vähäkangas; Henni M Helppi; Risto Bloigu; Paavo Pääkkö; Taina Turpeenniemi-Hujanen
Journal:  Head Neck Oncol       Date:  2011-04-22

3.  Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.

Authors:  Glen J Weiss; Winnie S Liang; Tyler Izatt; Shilpi Arora; Irene Cherni; Robert N Raju; Galen Hostetter; Ahmet Kurdoglu; Alexis Christoforides; Shripad Sinari; Angela S Baker; Raghu Metpally; Waibhav D Tembe; Lori Phillips; Daniel D Von Hoff; David W Craig; John D Carpten
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

4.  Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.

Authors:  R J Shaw; T Liloglou; S N Rogers; J S Brown; E D Vaughan; D Lowe; J K Field; J M Risk
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

5.  Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients.

Authors:  Andreas Knopf; Justine Lempart; Murat Bas; Julia Slotta-Huspenina; Naglaa Mansour; Marie Kristin Fritsche
Journal:  Oncotarget       Date:  2015-02-20

6.  Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma.

Authors:  Lorea Manterola; Pablo Aguirre; Erika Larrea; María Arestín; Ayman Gaafar; Kepa Elorriaga; Ibai Goicoechea; María Armesto; Marta Fernández-Mercado; Ignacio Zabalza; Juan Carlos López-Duque; Ekhiñe Larruskain; Jon Alexander Sistiaga; Mikel Landa; Aitor Zabala; Francisco Santaolalla; José Antonio Municio; Ángel Ispizua; Juana María García-Pedrero; Juan Pablo Rodrigo; Charles Henderson Lawrie
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

7.  Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma.

Authors:  Nina Lapke; Yen-Jung Lu; Chun-Ta Liao; Li-Yu Lee; Chien-Yu Lin; Hung-Ming Wang; Shu-Hang Ng; Shu-Jen Chen; Tzu-Chen Yen
Journal:  Oncotarget       Date:  2016-07-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.